Design (Testphase)
Risk & Weakness
Going Concern (Distress Proxy)
161
Findings
August 3, 2026
last calculated
Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q) · Market filter active: the list shows 100 hits from US
Going concern refers to serious doubt about whether a company can continue to operate. This scanner takes the classic warning signs: Altman Z″ in the distress zone (<1.1), interest coverage <1 (earnings don't cover interest), and negative operating cash flow (burning cash). Note: this is a quantitative proxy, NOT the actual auditor's note from the annual report — we could add that via an EDGAR text search ('substantial doubt … going concern').
Global filters: market cap of $50B or less (mega caps are cut from every scanner); 10- and 30-day ADR must be ≥ 1% (too little movement gets cut); fundamentally healthy names (Piotroski ≥ 5 or Fundamental Rating ≥ 55 out of 100) are excluded.
🔔 Watch scanner
Terms in This Scanner Explained
(17)
- ADR (Average Daily Range)
- The average daily swing of a stock in percent - measured over 10 or 30 trading days (columns "ADR 10D/30D"). An ADR of 5% means: on a normal day the gap between the intraday low and high runs about 5%. Traders look for movement - that is why stocks with an ADR under 1% are filtered out globally. Not to be confused with ADR meaning "American Depositary Receipt" (a US certificate for foreign shares) - here ADR always means the daily swing.
- AI Classification
- Our company-by-company assessment of the AI boom based on SEC filings (the last four quarterly 10-Q reports and two annual 10-K reports): "Sells AI" (AI is a revenue source), "Threatened" (AI is a concrete business risk), "Uses AI" (operational use), or "Neutral" (no material AI exposure). Every classification requires at least two direct quote citations - otherwise the column shows "-". Not a quality judgment or a buy recommendation; the full file is on the stock page, methodology at /stocks/ai-rating-methodology.
- Altman Z-Score
- A bankruptcy early-warning system developed by Edward Altman: several balance-sheet ratios are combined into one score. We use the Z″ variant, built from four balance-sheet ratios — it is designed for service companies and non-manufacturers and uses book value instead of market value. Values from 2.6 up are considered a safe zone, values below 1.1 a distress zone with elevated bankruptcy risk; in between lies a grey area. Because the classic Altman Z is calculated differently, the two numbers are not directly comparable. The formula does not fit banks, insurers, or real-estate stocks.
- Analysis (Full Company Analysis)
- If the Analysis column shows "Read," there is an in-depth TickerGuard company analysis for this stock: business model, scanner findings, quarterly results, evidence from SEC filings, plus opportunities and risks. One click opens it directly.
- Avg/Yr 3Y (Average Annual Return)
- The stock's average annual return over the past 3 years. Shows at a glance whether a stock delivers over the long run or just had a short hot streak.
- Earnings Date
- The date of the next quarterly earnings report. Price gaps in either direction are common around this date - that is why we color it red when it is 7 days away or less, and yellow when it is 14 days away or less: elevated risk for fresh positions.
- EPS (Earnings per Share)
- Quarterly earnings divided by the number of shares outstanding. The most important growth metric: if EPS rises strongly over several quarters, the company is earning more money per share.
- Free Cash Flow (FCF)
- Operating cash flow minus capital expenditures - the money left over for everything else (debt paydown, acquisitions, or buybacks). Consistently positive free cash flow is one of the most honest signs of a healthy business model.
- Funda Rating (Fundamental Rating A+ to F)
- Our proprietary fundamental rating from 0 to 100 points with a school-grade rank from A+ to F. 50 points is the average across the universe, 100 the best possible score. Every stock is scored against all others by percentile: growth in earnings and revenue, earnings surprises, analyst estimates, and quality criteria such as margins, cash flow, and balance-sheet strength. Grades: A+ from 95, A from 75, B from 55, C from 45, D from 25, E from 5, F below — A/A+ are the fundamentally strongest stocks in the universe.
- Going Concern
- The assumption in a company's annual report that it can continue operating. If auditors raise "substantial doubt" about this, it is one of the sharpest warnings there is - the company could run out of cash.
- Market Capitalization (Mkt Cap)
- The market value of the company: share price x total shares outstanding, shown here in billions of dollars. Micro caps (< $0.3B) are small and volatile, mega caps (> $200B) are heavyweights. Our scanner universe is deliberately capped at $50B - we look for stocks with room to run.
- Net Margin
- How much of revenue is left as profit? Net income divided by revenue, in percent. A 20% margin means: out of every dollar of revenue, 20 cents is left as profit. Rising margins are a strong quality signal.
- Operating Cash Flow (OCF)
- The cash that actually flows into the company from day-to-day operations - without accounting effects such as depreciation. A company can report book profits while still burning cash; operating cash flow reveals that.
- Piotroski F-Score
- A balance-sheet health check developed by Joseph Piotroski: 9 yes/no criteria covering earnings, cash flow, leverage, and efficiency produce a score from 0 to 9. Scores of 7 or higher are considered financially very solid, scores under 3 a warning sign.
- Sector & Industry
- Two levels of industry classification: sector is broad (e.g., Technology), industry is narrow (e.g., Semiconductors). Many strategies watch industry strength, because strong stocks are almost always found in strong industries.
- Stage (Weinstein Stages 1-4)
- Stan Weinstein divides every price chart into four stages: Stage 1 = basing (sideways after a downtrend), Stage 2 = uptrend (the only buying stage), Stage 3 = topping, Stage 4 = downtrend (avoid, or short candidate). Measured against the 30-week line (150-day moving average) and its slope.
- Stress RS (Strength on Stress Days)
- A stress day is a day on which both the overall market and the stock's own sector fell at least 0.5%. Stress RS counts on how many of these days the stock still closed green (shown as "g/n" = green days out of n stress days) and turns that into a rating from 1 to 99. High values point to buyers stepping in even on weak days - often a sign of institutional accumulation.
Hit List
Filter ▾
Rating (traffic light)
Stage
Funda Rating
Piotroski
Columns ▾
This scanner's columns
Extra columns
Tip: clicking a column header sorts the table by that column; a second click flips the direction.
| Symbol | Earnings | Avg/Y 3Y | Stress RS | Stage | Funda Rating | Piotroski | MktCap | Industry | AI Rating | Deep Dive | Deep-Dive Report | Sector | Price | YTD | 6 Mo. | 1 Year | Off High | Price Target | RS | EPS Rating | ADR 10D | ADR 30D | Beta | P/E | P/E (f) | P/S | P/B | P/FCF | PEG | EV/EBITDA | EBIT Margin | Gross Margin | Net Margin | ROE | ROA | Debt/Eq | Equity Ratio | Sales +/Y | Growth Score | Div. Yield | Payout Ratio | Altman Z | Inst. % | Short % | Analysts |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| VIAV Viavi Solutions Inc | 08/06 | +127 % | 72 7/25 | Stage 2 | C 48 | 4 of 9 | 9.3 $ | Communication Equipment | Sells AI | — | — | Technology | 37.00 $ | +180.4 % | +159.6 % | +267.7 % | −16.5 % | +74.5 % | 98 | 9 | 8.6 % | 8.4 % | 1.19 | — | 29.6 | 6.8 | 10.8 | 203.9 | 1.34 | 82.0 | 12.2 % | 60.7 % | -4.0 % | -7.0 % | 3.6 % | 7.85 | 33.5 % | +8.4 % | 4 | 0.0 % | 0.0 % | -85.0 | 97.3 % | 6.8 % | 3.8 (9) |
| AIP Arteris Inc | 08/04 | +177 % | 61 6/25 | Stage 2 | C 48 | 3 of 9 | 1.4 $ | Semiconductors | Sells AI | — | — | Technology | 29.90 $ | +165.9 % | +197.1 % | +203.0 % | −3.8 % | +27.8 % | 98 | 42 | 7.1 % | 7.5 % | 1.92 | — | 0.0 | 18.4 | 501.5 | — | — | -7.7 | -38.0 % | 88.8 % | -44.9 % | -1,369.6 % | -17.9 % | 2.11 | 1.8 % | +22.3 % | 6 | 0.0 % | 0.0 % | -3.7 | 61.1 % | 7.3 % | 4.5 (4) |
| INBX Inhibrx Biosciences, Inc. | 08/12 | — | 55 5/22 | Stage 2 | D 32 | 2 of 9 | 1.3 $ | Biotechnology | Neutral | — | — | Healthcare | 82.10 $ | +17.6 % | +18.8 % | +274.3 % | −38.6 % | +238.0 % | 97 | 42 | 6.9 % | 7.5 % | 3.43 | — | 0.0 | 965.4 | 182.9 | — | — | 0.0 | — | -7,697.5 % | 0.0 % | -354.7 % | -36.1 % | -0.28 | — | +550.0 % | 4 | 0.0 % | 0.0 % | -1.0 | 83.1 % | 31.3 % | — |
| HYMC Hycroft Mining Holding Corporation | 07/29 | +212 % | 51 5/23 | Stage 1 | D 35 | 4 of 9 | 1.8 $ | Gold | Neutral | — | — | Basic Materials | 19.50 $ | -2.7 % | -6.3 % | +499.1 % | −62.7 % | +43.6 % | 97 | 42 | 8.2 % | 8.0 % | 2.72 | — | 0.0 | — | 8.6 | — | — | -0.8 | — | -405.6 % | 0.0 % | -86.1 % | -26.9 % | 0.00 | — | -100.0 % | 3 | 0.0 % | 0.0 % | 0.6 | 33.1 % | 23.2 % | 3.0 (1) |
| OTLK OUTLOOK THERAPEUTICS INC | 08/13 | -32 % | 71 6/22 | Stage 3 | D 29 | 4 of 9 | 0.1 $ | Biotechnology | Uses AI | — | Healthcare | 0.98 $ | +7.6 % | -7.7 % | -50.2 % | −52.5 % | +241.6 % | 97 | 42 | 16.8 % | 20.7 % | 0.78 | — | 2.8 | 483.3 | — | — | — | -4.1 | — | -360.8 % | 0.0 % | -3.7 % | -184.8 % | — | — | +730.9 % | — | 0.0 % | 0.0 % | -116.1 | 6.9 % | 10.1 % | — | |
| ABSI Absci Corp | 08/11 | +106 % | 5 1/22 | Stage 2 | D 26 | 3 of 9 | 1.3 $ | Biotechnology | Sells AI | — | — | Healthcare | 7.80 $ | +112.3 % | +218.8 % | +174.9 % | −9.2 % | +76.6 % | 96 | 42 | 16.7 % | 12.8 % | 2.33 | — | 0.0 | 709.5 | 7.0 | — | — | -0.4 | — | -4,455.0 % | 0.0 % | -63.9 % | -37.3 % | 0.03 | — | -38.2 % | 4 | 0.0 % | 0.0 % | -0.3 | 72.9 % | 25.8 % | 4.6 (9) |
| FIRY FIRY | 08/06 | -24 % | — | Stage 2 | C 46 | 4 of 9 | 0.0 $ | Electronic Gaming & Multimedia | Sells AI | — | Communication Services | 9.40 $ | +111.6 % | -36.1 % | +36.8 % | −58.2 % | — | 95 | 42 | 11.2 % | 11.7 % | 4.54 | — | 0.0 | — | 1.4 | — | — | -0.2 | — | 87.8 % | -57.5 % | -49.6 % | -12.5 % | 1.26 | — | -31.3 % | 4 | 0.0 % | 0.0 % | -9.1 | 37.8 % | 23.4 % | — | |
| IBRX Immunitybio Inc | 08/04 | +57 % | 56 5/22 | Stage 2 | C 51 | 3 of 9 | 7.4 $ | Biotechnology | Uses AI | — | Healthcare | 7.20 $ | +269.7 % | +309.8 % | +191.5 % | −37.3 % | +77.1 % | 94 | 42 | 7.8 % | 7.0 % | 0.08 | — | 0.0 | 52.7 | — | — | — | -9.0 | -157.9 % | 99.3 % | 0.0 % | 0.0 % | -34.4 % | — | -134.5 % | +668.3 % | 6 | 0.0 % | 0.0 % | -23.1 | 17.6 % | 34.6 % | 4.6 (5) | |
| QMCO Quantum Corporation | — | -32 % | 62 6/25 | Stage 2 | D 42 | 4 of 9 | 0.3 $ | Computer Hardware | Uses AI | — | Technology | 10.60 $ | +114.1 % | +60.8 % | +32.8 % | −30.0 % | +55.7 % | 94 | 42 | 14.0 % | 14.5 % | 2.96 | — | 1.9 | 1.2 | 0.1 | — | 0.77 | 236.9 | — | 36.9 % | -36.1 % | 0.0 % | -6.6 % | -0.04 | — | -12.1 % | — | 0.0 % | 0.0 % | -26.0 | 12.8 % | 5.8 % | 3.0 (2) | |
| RFL Rafael Holdings, Inc. | — | +9 % | 84 7/21 | Stage 2 | D 32 | 2 of 9 | 0.1 $ | Real Estate Services | Neutral | — | — | Real Estate | 1.90 $ | +126.3 % | +167.8 % | +14.8 % | −8.1 % | — | 94 | 42 | 12.5 % | 10.6 % | 0.29 | — | 0.0 | 112.2 | 1.3 | — | — | 5.4 | — | 95.1 % | 0.0 % | -37.6 % | -22.8 % | 0.01 | — | +44.0 % | — | 0.0 % | 0.0 % | 0.8 | 7.3 % | 0.3 % | — |
| RCUS Arcus Biosciences Inc | 08/05 | +16 % | 40 4/22 | Stage 2 | D 34 | 0 of 9 | 3.5 $ | Biotechnology | Neutral | — | Healthcare | 28.20 $ | +18.3 % | +34.4 % | +208.8 % | −3.8 % | +30.6 % | 93 | 42 | 6.2 % | 6.0 % | 0.80 | — | 0.0 | 15.0 | 6.9 | — | — | 4.0 | -788.2 % | -121.6 % | -156.4 % | -70.0 % | -23.1 % | 0.22 | 52.6 % | -4.3 % | 4 | 0.0 % | 0.0 % | 1.0 | 72.4 % | 16.4 % | 4.5 (13) | |
| TSHA Taysha Gene Therapies Inc | 08/11 | +87 % | — | Stage 2 | D 35 | 4 of 9 | 0.0 $ | Biotechnology | Neutral | — | Healthcare | 5.90 $ | +24.7 % | +13.9 % | +114.7 % | −14.9 % | +109.3 % | 93 | 50 | 7.2 % | 6.9 % | 1.16 | — | 0.0 | — | — | — | — | -0.6 | -1,774.4 % | 100.0 % | 0.0 % | -97.3 % | -37.8 % | — | 70.6 % | +17.3 % | 6 | 0.0 % | 0.0 % | 0.4 | 95.8 % | 13.7 % | 1.0 (10) | |
| CORZ Core Scientific, Inc. | 08/14 | — | 46 5/25 | Stage 2 | D 44 | 4 of 9 | 6.6 $ | Software - Infrastructure | – | — | — | Technology | 20.70 $ | +100.3 % | +66.6 % | +53.0 % | −10.5 % | +79.3 % | 93 | 80 | 6.3 % | 6.5 % | 5.50 | — | 166.7 | 14.9 | 0.0 | — | — | 454.9 | -18.8 % | 32.1 % | 0.0 % | 0.0 % | -2.4 % | -1.57 | -42.5 % | -37.5 % | 4 | 0.0 % | 0.0 % | -5.1 | 124.5 % | 22.6 % | 4.7 (16) |
| PGEN Precigen Inc | 08/11 | +125 % | 39 4/22 | Stage 2 | C 54 | 4 of 9 | 2.2 $ | Biotechnology | Neutral | — | — | Healthcare | 6.30 $ | +28.2 % | +41.3 % | +266.7 % | −2.8 % | +98.4 % | 93 | 42 | 6.5 % | 6.9 % | 1.01 | — | 312.5 | 70.9 | 117.8 | — | — | -3.3 | -25.8 % | -35.4 % | 0.0 % | -1,145.4 % | -42.1 % | 4.86 | 14.6 % | +146.7 % | 2 | 0.0 % | 0.0 % | -57.6 | 71.1 % | 21.2 % | 3.8 (4) |
| REPL Replimune Group Inc | 07/02 | -31 % | 55 5/22 | Stage 3 | D 32 | 1 of 9 | 0.9 $ | Biotechnology | Neutral | — | Healthcare | 11.20 $ | +17.5 % | -40.2 % | +59.3 % | −15.9 % | +7.1 % | 92 | 42 | 9.2 % | 10.0 % | 0.87 | — | 0.0 | 615.3 | 4.6 | — | — | -0.2 | — | — | 0.0 % | -90.9 % | -45.0 % | 0.36 | — | — | 2 | 0.0 % | 0.0 % | -8.4 | 96.9 % | 49.9 % | 4.4 (8) | |
| ARMP Armata Pharmaceuticals Inc | 08/11 | +51 % | 56 5/22 | Stage 1 | D 29 | 4 of 9 | 0.2 $ | Biotechnology | Neutral | — | — | Healthcare | 4.50 $ | +11.6 % | +0.8 % | +85.3 % | −60.2 % | +169.2 % | 91 | 42 | 11.0 % | 10.5 % | 1.27 | — | 0.0 | 31.3 | — | — | — | -3.5 | — | -215.2 % | 0.0 % | -3,439.4 % | -25.3 % | — | — | -5.2 % | — | 0.0 % | 0.0 % | -52.2 | 10.5 % | 1.9 % | — |
| CLPT Clearpoint Neuro Inc | 08/11 | +61 % | 40 4/22 | Stage 3 | D 44 | 4 of 9 | 0.5 $ | Medical Devices | Neutral | — | — | Healthcare | 14.90 $ | +35.5 % | +34.1 % | +43.7 % | −40.3 % | +90.2 % | 90 | 42 | 11.6 % | 9.0 % | 1.24 | — | 12.1 | 11.1 | 23.8 | — | 0.61 | -7.1 | — | 62.3 % | -71.6 % | -149.7 % | -25.0 % | 3.38 | — | +17.8 % | — | 0.0 % | 0.0 % | -3.1 | 50.6 % | 12.8 % | 5.0 (2) |
| SPIR Spire Global Inc | 08/12 | +124 % | 85 10/29 | Stage 2 | D 40 | 4 of 9 | 0.5 $ | Specialty Business Services | Sells AI | — | — | Industrials | 11.50 $ | +132.5 % | +114.7 % | +14.3 % | −38.3 % | +81.5 % | 90 | 42 | 9.1 % | 11.1 % | 2.52 | 7.4 | 0.0 | 6.7 | 5.2 | — | — | 5.9 | — | 42.3 % | 77.1 % | 101.2 % | -27.2 % | 0.13 | — | -35.2 % | — | 0.0 % | 0.0 % | -8.1 | 39.9 % | 11.8 % | 4.6 (5) |
| KPTI Karyopharm Therapeutics Inc | 08/10 | -23 % | 94 9/22 | Stage 2 | D 38 | 4 of 9 | 0.0 $ | Biotechnology | Uses AI | — | — | Healthcare | 1.90 $ | +31.1 % | +35.0 % | -49.6 % | −13.9 % | +42.7 % | 89 | 42 | 7.7 % | 8.7 % | 0.81 | — | 0.0 | 0.3 | 2.4 | — | — | -1.9 | — | 13.5 % | -129.0 % | -891.1 % | -40.6 % | -0.87 | — | +0.6 % | — | 0.0 % | 0.0 % | -48.8 | 83.7 % | 24.8 % | — |
| CYTK Cytokinetics Inc | 08/06 | +8 % | 68 6/22 | Stage 2 | D 39 | 3 of 9 | 10.4 $ | Biotechnology | Neutral | — | Healthcare | 77.10 $ | +25.9 % | +36.0 % | +104.9 % | −2.6 % | +39.8 % | 88 | 42 | 4.6 % | 4.1 % | 0.42 | — | 117.6 | 97.8 | 57.5 | — | — | -15.8 | -948.7 % | -290.7 % | 0.0 % | -572.2 % | -31.5 % | -1.56 | -64.9 % | +376.6 % | 3 | 0.0 % | 0.0 % | -7.3 | 118.8 % | 19.4 % | 4.3 (21) | |
| ECOR Electrocore LLC | 08/05 | +35 % | 70 6/22 | Stage 2 | C 45 | 4 of 9 | 0.1 $ | Medical Devices | – | — | — | Healthcare | 6.10 $ | +86.2 % | +66.4 % | -12.1 % | −31.5 % | +166.6 % | 87 | 42 | 11.0 % | 11.5 % | 0.89 | — | 384.6 | 1.5 | 29.6 | — | — | 0.2 | — | 87.3 % | -44.1 % | -478.7 % | -58.1 % | -1.67 | — | +27.2 % | — | 0.0 % | 0.0 % | -44.7 | 9.2 % | 2.6 % | — |
| HURA TuHURA Biosciences Inc | 08/13 | -33 % | 82 7/22 | Stage 3 | E 19 | 3 of 9 | 0.1 $ | Biotechnology | Neutral | — | Healthcare | 2.20 $ | +248.7 % | +177.9 % | -12.5 % | −33.6 % | +210.4 % | 86 | 42 | 10.2 % | 9.0 % | — | — | 0.0 | — | — | — | — | 0.0 | — | — | 0.0 % | -187.2 % | -81.9 % | — | — | — | — | 0.0 % | 0.0 % | -16.0 | 15.0 % | 15.8 % | — | |
| MIRM Mirum Pharmaceuticals Inc | 08/05 | +102 % | 68 6/22 | Stage 2 | C 45 | 3 of 9 | 6.3 $ | Biotechnology | – | — | — | Healthcare | 106.00 $ | +40.6 % | +52.3 % | +105.0 % | −1.9 % | +38.2 % | 86 | 42 | 5.0 % | 5.0 % | 0.49 | — | 39.7 | 11.0 | 28.1 | — | — | 341.2 | -39.5 % | 81.4 % | -140.2 % | -335.8 % | -5.9 % | 1.34 | 27.2 % | +54.7 % | 7 | 0.0 % | 0.0 % | -5.4 | 114.4 % | 15.6 % | 4.6 (10) |
| CLMT Calumet, Inc. | 08/14 | +35 % | 99 18/23 | Stage 2 | D 44 | 3 of 9 | 3.9 $ | Specialty Chemicals | – | — | — | Basic Materials | 44.20 $ | +65.2 % | +81.8 % | +177.2 % | −11.6 % | -10.4 % | 86 | 95 | 4.7 % | 4.3 % | 0.72 | — | 11.4 | 0.9 | 24.9 | 45.7 | 0.65 | 119.5 | -27.8 % | 6.1 % | -4.5 % | -1,172.2 % | -2.0 % | -2.24 | -37.9 % | -1.3 % | 3 | 0.0 % | 0.0 % | 0.1 | 53.3 % | 5.3 % | 3.9 (7) |
| ATRA Atara Biotherapeutics Inc | 08/10 | -29 % | 81 7/22 | Stage 3 | D 36 | 4 of 9 | 0.1 $ | Biotechnology | – | — | — | Healthcare | 8.40 $ | -38.3 % | -67.1 % | -27.3 % | −46.6 % | +33.7 % | 85 | 42 | 8.3 % | 8.3 % | 0.09 | — | 232.6 | 3.3 | 13.3 | — | — | 2.2 | — | 70.1 % | -40.9 % | -2,014.9 % | -3.8 % | -0.27 | — | -6.3 % | — | 0.0 % | 0.0 % | -327.5 | 52.5 % | 7.8 % | — |
| RDNW RideNow Group, Inc. | 08/10 | -14 % | 86 11/31 | Stage 2 | D 38 | 3 of 9 | 0.2 $ | Auto & Truck Dealerships | – | — | — | Consumer Cyclical | 6.20 $ | +16.5 % | +32.6 % | +192.9 % | −20.4 % | +32.2 % | 85 | 42 | 7.1 % | 7.1 % | 1.18 | — | 0.0 | 0.2 | 2.3 | — | — | 65.9 | — | 27.5 % | -4.3 % | -878.5 % | 3.1 % | 1.99 | — | -10.5 % | — | 0.0 % | 0.0 % | 1.1 | 43.4 % | 7.6 % | — |
| SHIM Shimmick Corporation Common Stock | 08/13 | — | 49 6/29 | Stage 1 | D 41 | 4 of 9 | 0.2 $ | Engineering & Construction | Neutral | — | — | Industrials | 3.80 $ | +25.3 % | +50.2 % | +113.6 % | −39.7 % | +83.8 % | 83 | 42 | 7.6 % | 8.4 % | 0.71 | — | 72.5 | 0.3 | 65.0 | — | — | 1,635.2 | — | 8.7 % | -4.4 % | -696.6 % | -4.3 % | -1.33 | — | +2.6 % | — | 0.0 % | 0.0 % | 0.3 | 8.7 % | 0.2 % | — |
| PLUG Plug Power Inc | 08/10 | -24 % | 66 8/29 | Stage 2 | D 43 | 3 of 9 | 2.9 $ | Electrical Equipment & Parts | – | — | — | Industrials | 2.10 $ | +37.6 % | +23.3 % | +37.3 % | −43.9 % | +68.9 % | 82 | 42 | 6.8 % | 8.2 % | 2.17 | — | 13.1 | 4.0 | 3.9 | — | 0.84 | -2.2 | -63.6 % | -31.2 % | -227.1 % | -128.8 % | -13.6 % | 1.35 | 31.7 % | +12.9 % | 2 | 0.0 % | 0.0 % | -10.6 | 68.9 % | 26.7 % | 3.2 (20) |
| IHRT iHeartMedia Inc Class A | 08/10 | +5 % | 50 5/24 | Stage 1 | D 26 | 4 of 9 | 0.5 $ | Broadcasting | – | — | — | Communication Services | 3.60 $ | -6.0 % | -0.4 % | +92.0 % | −37.4 % | +0.7 % | 81 | 89 | 7.6 % | 8.1 % | 2.20 | — | 51.3 | 0.1 | — | — | 5.03 | 19.1 | — | 58.6 % | -7.3 % | -2,444.0 % | 2.7 % | — | — | +0.3 % | 5 | 0.0 % | 0.0 % | 0.7 | 86.6 % | 7.4 % | 2.8 (4) |
| REAL TheRealReal Inc | 08/06 | +260 % | 21 4/31 | Stage 4 | C 54 | 3 of 9 | 1.5 $ | Luxury Goods | Uses AI | — | Consumer Cyclical | 12.10 $ | -22.6 % | -24.8 % | +129.9 % | −28.5 % | +42.6 % | 79 | 42 | 7.3 % | 6.4 % | 2.67 | — | 185.2 | 2.0 | 4.7 | 117.1 | — | 93.7 | -1.2 % | 74.5 % | -9.0 % | -932.7 % | -2.2 % | -1.29 | -93.1 % | +15.4 % | 4 | 0.0 % | 0.0 % | -9.2 | 98.4 % | 17.1 % | 3.6 (7) | |
| ACHV Achieve Life Sciences Inc | 08/06 | -5 % | 56 5/22 | Stage 2 | D 26 | 3 of 9 | 0.7 $ | Biotechnology | – | — | — | Healthcare | 6.40 $ | +0.8 % | +39.7 % | +146.0 % | −7.5 % | +115.6 % | 79 | 42 | 8.7 % | 8.2 % | 2.22 | — | 35.3 | — | — | — | 17.68 | -2.4 | — | — | 0.0 % | -496.2 % | -108.4 % | — | — | -100.0 % | — | 0.0 % | 0.0 % | -29.4 | 61.0 % | 14.4 % | 4.9 (8) |
| RDZN Roadzen Inc. | — | -31 % | 74 7/25 | Stage 1 | C 51 | 4 of 9 | 0.1 $ | Software - Application | Sells AI | — | — | Technology | 1.20 $ | -36.1 % | -24.9 % | -8.7 % | −43.4 % | +244.8 % | 79 | 42 | 9.6 % | 8.4 % | 1.20 | — | 0.0 | 2.0 | — | — | — | -4.4 | — | 61.3 % | -40.9 % | 0.0 % | -20.5 % | — | — | -5.2 % | — | 0.0 % | 0.0 % | -20.2 | 3.0 % | 1.2 % | — |
| ABOS Acumen Pharmaceuticals Inc | 08/11 | -19 % | 81 7/22 | Stage 2 | E 23 | 1 of 9 | 0.2 $ | Biotechnology | – | — | — | Healthcare | 2.20 $ | +14.2 % | +28.2 % | +53.6 % | −38.6 % | +234.8 % | 78 | 42 | 7.9 % | 6.8 % | 0.34 | — | 0.0 | — | 1.9 | — | — | -0.6 | — | -31,894.5 % | 0.0 % | -93.2 % | -42.4 % | 0.36 | — | -100.0 % | — | 0.0 % | 0.0 % | -6.5 | 64.2 % | 3.8 % | — |
| SRRK Scholar Rock Holding Corp | 08/05 | +8 % | 26 3/22 | Stage 2 | D 33 | 1 of 9 | 5.7 $ | Biotechnology | – | — | — | Healthcare | 47.30 $ | +16.4 % | +19.8 % | +27.7 % | −0.1 % | +25.4 % | 77 | 42 | 4.7 % | 4.7 % | 0.68 | — | 0.0 | — | 20.9 | — | — | -2.1 | 0.0 % | — | 0.0 % | -138.9 % | -54.3 % | 0.75 | 51.6 % | -100.0 % | 3 | 0.0 % | 0.0 % | -3.7 | 116.6 % | 18.4 % | 4.6 (10) |
| LASE Laser Photonics Corporation | 08/21 | -32 % | 90 11/29 | Stage 3 | D 25 | 2 of 9 | 0.1 $ | Specialty Industrial Machinery | Sells AI | — | Industrials | 0.98 $ | — | — | -64.8 % | −71.3 % | — | 77 | 3 | 16.3 % | 17.9 % | 2.27 | — | 0.0 | 7.2 | 5.8 | — | — | 28.8 | -303.2 % | -1.2 % | -268.7 % | -727.4 % | -48.1 % | — | -53.3 % | +132.0 % | — | 0.0 % | 0.0 % | -4.9 | 12.0 % | 9.3 % | 5.0 (1) | |
| BKSY Blacksky Technology Inc | 08/06 | +25 % | 99 15/29 | Stage 1 | D 31 | 2 of 9 | 0.9 $ | Specialty Business Services | Sells AI | — | — | Industrials | 23.10 $ | +43.5 % | +33.6 % | +19.8 % | −54.0 % | +75.3 % | 76 | 42 | 9.1 % | 10.7 % | 2.59 | — | 0.0 | 9.0 | — | — | — | 6.6 | — | 69.3 % | -89.1 % | -102.7 % | -10.6 % | — | — | +4.4 % | 5 | 0.0 % | 0.0 % | -2.1 | 68.4 % | 21.7 % | 5.0 (6) |
| KURA Kura Oncology Inc | 08/06 | -2 % | 56 5/22 | Stage 3 | D 43 | 2 of 9 | 0.8 $ | Biotechnology | – | — | — | Healthcare | 9.00 $ | -0.1 % | -0.8 % | +48.9 % | −17.1 % | +246.3 % | 75 | 42 | 5.3 % | 6.1 % | 0.35 | — | 0.0 | 11.2 | 7.4 | — | — | -2.5 | — | -263.9 % | 0.0 % | -124.7 % | -28.4 % | 0.23 | — | +25.2 % | 3 | 0.0 % | 0.0 % | -0.6 | 96.4 % | 15.9 % | 4.5 (15) |
| ALLO Allogene Therapeutics Inc | 08/12 | -19 % | 16 2/22 | Stage 2 | D 33 | 2 of 9 | 0.7 $ | Biotechnology | – | — | — | Healthcare | 1.90 $ | +51.1 % | +58.6 % | +52.9 % | −53.8 % | +373.7 % | 75 | 42 | 6.7 % | 6.7 % | 0.46 | — | 0.0 | — | — | — | — | -1.0 | — | — | 0.0 % | -52.3 % | -26.0 % | — | — | -100.0 % | 4 | 0.0 % | 0.0 % | -10.0 | 53.3 % | 19.2 % | 4.4 (14) |
| NPCE Neuropace Inc | 08/11 | +85 % | — | Stage 2 | C 49 | 2 of 9 | 0.0 $ | Medical Devices | – | — | — | Healthcare | 12.90 $ | +3.1 % | +2.1 % | +51.5 % | −16.5 % | +22.2 % | 74 | 50 | 4.7 % | 4.7 % | 1.89 | — | 0.0 | — | 32.2 | — | — | -16.9 | — | 78.3 % | -21.7 % | -111.4 % | -10.0 % | 4.88 | — | +25.1 % | 4 | 0.0 % | 0.0 % | -11.4 | 96.3 % | 2.1 % | — |
| IMDX Insight Molecular Diagnostics Inc. | 08/10 | +11 % | 57 5/22 | Stage 4 | D 37 | 2 of 9 | 0.1 $ | Diagnostics & Research | Neutral | — | — | Healthcare | 4.70 $ | -28.4 % | -6.9 % | +84.5 % | −34.3 % | +49.1 % | 74 | 42 | 8.9 % | 10.6 % | 1.77 | — | 0.0 | 78.4 | 73.2 | — | — | -1.3 | — | 51.1 % | 0.0 % | -23,603.1 % | -43.4 % | -0.29 | — | +115.6 % | — | 0.0 % | 0.0 % | -34.6 | 61.4 % | 7.2 % | — |
| CDXS Codexis Inc | 08/12 | -5 % | 16 2/22 | Stage 2 | C 49 | 4 of 9 | 0.1 $ | Biotechnology | – | — | — | Healthcare | 1.40 $ | +46.6 % | +38.7 % | -47.8 % | −41.9 % | +192.6 % | 73 | 42 | 6.9 % | 6.5 % | 2.50 | — | 149.3 | 1.7 | — | — | 13.53 | -10.7 | — | 23.8 % | -41.0 % | -68.9 % | -12.5 % | — | — | +18.6 % | — | 0.0 % | 0.0 % | -10.0 | 74.4 % | 3.6 % | — |
| CABA Cabaletta Bio Inc | 08/06 | -25 % | 29 3/22 | Stage 2 | E 23 | 2 of 9 | 0.4 $ | Biotechnology | – | — | — | Healthcare | 2.70 $ | +37.9 % | +42.0 % | +76.3 % | −31.0 % | +395.4 % | 73 | 42 | 7.4 % | 7.4 % | 3.26 | — | 0.0 | — | — | — | — | -3.4 | — | — | 0.0 % | -156.0 % | -71.6 % | — | — | -100.0 % | — | 0.0 % | 0.0 % | -10.9 | 63.6 % | 27.8 % | 4.5 (12) |
| SGHT Sight Sciences Inc | 08/06 | -10 % | 7 1/22 | Stage 4 | D 38 | 4 of 9 | 0.3 $ | Medical Devices | – | — | — | Healthcare | 5.30 $ | -31.8 % | -35.5 % | +58.0 % | −40.9 % | +56.4 % | 73 | 42 | 6.8 % | 6.6 % | 2.38 | — | 0.0 | 3.6 | — | — | — | -4.2 | — | 86.2 % | -46.8 % | -56.6 % | -14.3 % | — | — | -3.1 % | — | 0.0 % | 0.0 % | -4.2 | 54.0 % | 2.0 % | — |
| TEAD Teads B.V. | 08/06 | -26 % | 75 7/24 | Stage 3 | D 33 | 4 of 9 | 0.1 $ | Internet Content & Information | Threatened | — | — | Communication Services | 0.71 $ | +65.5 % | -10.0 % | -72.0 % | −65.2 % | +10.1 % | 72 | 30 | 13.2 % | 12.5 % | 1.65 | — | 0.0 | 0.1 | 1.5 | — | — | 98.7 | — | 33.6 % | -39.1 % | -190.9 % | -1.3 % | 13.00 | — | +46.1 % | — | 0.0 % | 0.0 % | -0.7 | 30.0 % | 11.3 % | — |
| PBFS Pioneer Bancorp Inc | 08/14 | +30 % | 71 6/22 | Stage 2 | C 50 | 3 of 9 | 0.4 $ | Banks - Regional | – | — | — | Financial Services | 17.20 $ | +26.4 % | +23.0 % | +40.3 % | −11.2 % | — | 72 | 29 | 4.2 % | 3.3 % | 0.40 | 20.4 | 0.0 | 3.3 | 1.2 | 32.6 | — | 0.0 | — | 100.0 % | 17.1 % | 6.2 % | 0.9 % | — | — | -10.7 % | — | 0.0 % | 0.0 % | -1.1 | 23.6 % | 1.1 % | — |
| SCLX Scilex Holding Company | 08/12 | -32 % | 58 5/22 | Stage 3 | D 40 | 4 of 9 | 0.0 $ | Drug Manufacturers - General | Neutral | — | — | Healthcare | 6.60 $ | -9.4 % | -9.4 % | -20.2 % | −79.3 % | +6,811.1 % | 72 | 42 | 13.4 % | 12.2 % | 1.73 | — | 2.7 | 1.4 | — | — | — | -2.6 | — | 59.7 % | 0.0 % | 0.0 % | -92.8 % | — | — | -46.5 % | — | 0.0 % | 0.0 % | -26.0 | 13.1 % | 3.7 % | — |
| UIS Unisys Corporation | 07/29 | -4 % | 4 1/25 | Stage 2 | D 34 | 3 of 9 | 0.2 $ | Information Technology Services | – | — | — | Technology | 2.90 $ | +31.2 % | +34.9 % | -30.5 % | −29.7 % | +57.1 % | 71 | 17 | 5.8 % | 7.6 % | 1.88 | — | 6.7 | 0.1 | 14.3 | 3.3 | 0.45 | 4.1 | — | 29.3 % | -17.7 % | 0.0 % | 3.1 % | -2.55 | — | -2.9 % | — | 0.0 % | 0.0 % | -1.4 | 81.8 % | 6.6 % | — |
| ZYME Zymeworks Inc. Common Stock | 08/06 | +65 % | 80 7/22 | Stage 1 | E 17 | 3 of 9 | 1.6 $ | Biotechnology | – | — | — | Healthcare | 21.90 $ | -9.3 % | -10.3 % | +74.7 % | −20.1 % | +79.6 % | 70 | 42 | 4.5 % | 4.1 % | 1.13 | — | 21.9 | 19.8 | 9.8 | — | — | 0.3 | -1,956.7 % | -67.0 % | -126.3 % | -42.0 % | -15.8 % | 0.10 | 34.2 % | +38.9 % | 2 | 0.0 % | 0.0 % | -0.2 | 99.2 % | 8.3 % | 4.5 (10) |
| FUN Six Flags Entertainment Corporation | 08/05 | -13 % | 74 9/31 | Stage 3 | D 36 | 4 of 9 | 1.7 $ | Leisure | – | — | — | Consumer Cyclical | 17.30 $ | +50.9 % | +43.3 % | -42.2 % | −32.9 % | +49.0 % | 67 | 8 | 6.6 % | 6.3 % | 0.38 | — | 1,000.0 | 0.6 | 6.3 | 60.6 | 2.43 | 14.2 | -107.8 % | 37.4 % | -52.8 % | -123.4 % | 2.2 % | 19.81 | 3.6 % | +14.5 % | 2 | 0.0 % | 0.0 % | 0.9 | 113.3 % | 22.0 % | 4.5 (14) |
| ARDX Ardelyx Inc | 08/03 | +24 % | 69 6/22 | Stage 1 | C 50 | 4 of 9 | 1.3 $ | Biotechnology | – | — | — | Healthcare | 5.00 $ | +6.0 % | -12.7 % | +16.8 % | −27.9 % | +226.0 % | 67 | 42 | 6.3 % | 5.1 % | 0.61 | — | 40.7 | 3.0 | — | — | — | 130.9 | -34.7 % | 74.6 % | -13.6 % | -39.5 % | -5.1 % | — | 29.5 % | +22.1 % | 5 | 0.0 % | 0.0 % | 0.5 | 70.7 % | 10.9 % | 4.6 (11) |
| BBIO BridgeBio Pharma Inc | 08/04 | +113 % | 68 6/22 | Stage 1 | C 54 | 3 of 9 | 15.7 $ | Biotechnology | – | — | — | Healthcare | 80.10 $ | -10.3 % | -5.9 % | +69.4 % | −18.0 % | +31.4 % | 59 | 42 | 3.7 % | 4.0 % | 0.95 | — | 0.0 | 27.0 | 142.2 | — | — | -9.4 | -54.5 % | 95.1 % | -124.4 % | -1,789.7 % | -28.0 % | -1.49 | -165.5 % | +126.3 % | 4 | 0.0 % | 0.0 % | -7.9 | 103.2 % | 14.7 % | 4.4 (19) |
| AQST Aquestive Therapeutics Inc | 08/10 | +58 % | 28 3/22 | Stage 3 | C 47 | 3 of 9 | 0.5 $ | Drug Manufacturers - Specialty & Generic | – | — | — | Healthcare | 3.70 $ | -22.1 % | -30.3 % | -3.8 % | −40.9 % | +140.2 % | 59 | 42 | 6.5 % | 5.1 % | 1.45 | — | 0.0 | 9.2 | 11.7 | — | — | -1.8 | — | 63.4 % | -137.1 % | 0.0 % | -28.7 % | -3.92 | — | -22.6 % | — | 0.0 % | 0.0 % | -5.4 | 60.6 % | 13.9 % | 4.6 (9) |
| HTFL Heartflow, Inc. | — | — | — | Stage 3 | C 51 | 4 of 9 | 0.0 $ | Health Information Services | – | — | — | Healthcare | 25.20 $ | +18.3 % | +14.5 % | — | −15.1 % | +5.8 % | 58 | 50 | 5.4 % | 7.0 % | — | — | 0.0 | — | — | — | — | 0.0 | — | 78.1 % | -58.4 % | -135.3 % | -16.2 % | — | — | +39.9 % | 4 | 0.0 % | 0.0 % | -0.9 | 78.8 % | 7.1 % | — |
| BIRD Allbirds Inc | 08/06 | -32 % | 21 4/31 | Stage 3 | E 17 | 3 of 9 | 0.0 $ | Apparel Retail | – | — | — | Consumer Cyclical | 2.20 $ | +24.9 % | -84.6 % | -78.0 % | −82.4 % | +227.1 % | 57 | 42 | 23.0 % | 13.8 % | 2.56 | — | 0.0 | 0.2 | 1.4 | — | — | -0.6 | — | 38.1 % | -53.4 % | -153.7 % | -38.8 % | 2.04 | — | -19.7 % | 1 | 0.0 % | 0.0 % | -23.1 | 35.4 % | 16.9 % | — |
| W Wayfair Inc | 08/03 | +16 % | 8 2/31 | Stage 4 | D 42 | 3 of 9 | 11.2 $ | Internet Retail | – | — | — | Consumer Cyclical | 84.90 $ | -15.5 % | -5.0 % | +29.3 % | −22.1 % | +12.7 % | 56 | 13 | 6.5 % | 6.8 % | 2.96 | — | 30.7 | 0.9 | 2,432.5 | 24.6 | 23.50 | 107.7 | 0.4 % | 30.4 % | -2.4 % | 0.0 % | 3.7 % | -1.28 | -99.0 % | +5.1 % | 3 | 0.0 % | 0.0 % | -4.4 | 113.3 % | 18.1 % | 3.8 (35) |
| MWYN Marwynn Holdings, Inc. Common stock | — | — | 82 10/31 | Stage 3 | D 36 | 4 of 9 | 0.0 $ | Furnishings, Fixtures & Appliances | – | — | — | Consumer Cyclical | 0.76 $ | +31.1 % | +18.9 % | -16.1 % | −53.3 % | — | 56 | 3 | 9.3 % | 9.9 % | — | — | 0.0 | 2.3 | 6.6 | — | — | 14.8 | — | 38.4 % | -68.9 % | -306.2 % | -58.6 % | 0.01 | — | -6.8 % | 3 | 0.0 % | 0.0 % | -14.6 | 0.6 % | 0.6 % | — |
| NEXT Nextdecade Corp | 07/30 | -1 % | — | Stage 2 | D 27 | 1 of 9 | 1.7 $ | Oil & Gas Equipment & Services | Neutral | — | Energy | 6.70 $ | +27.7 % | +28.2 % | -40.9 % | −40.8 % | +38.1 % | 54 | 50 | 7.0 % | 5.7 % | 1.51 | — | 0.0 | — | 21.7 | — | — | 196.5 | 0.0 % | — | 0.0 % | -18.6 % | -1.2 % | 89.31 | 0.8 % | — | — | 0.0 % | 0.0 % | -0.1 | 45.0 % | 13.1 % | 3.5 (2) | |
| EDIT Editas Medicine Inc | 08/11 | -27 % | 29 3/22 | Stage 3 | D 42 | 2 of 9 | 0.4 $ | Biotechnology | Neutral | — | Healthcare | 2.60 $ | +27.8 % | +27.2 % | +2.8 % | −36.9 % | +130.8 % | 54 | 42 | 8.7 % | 10.1 % | 2.10 | — | 0.0 | 10.3 | 92.6 | — | — | -1.4 | -883.2 % | -109.2 % | -281.6 % | -326.1 % | -27.0 % | 0.40 | 14.6 % | +25.4 % | — | 0.0 % | 0.0 % | -11.5 | 49.4 % | 14.5 % | 3.5 (15) | |
| MNKD MannKind Corp | 08/05 | +0 % | 69 6/22 | Stage 4 | D 38 | 2 of 9 | 1.2 $ | Biotechnology | Uses AI | — | Healthcare | 3.90 $ | -30.7 % | -28.5 % | +3.4 % | −39.6 % | +97.9 % | 53 | 19 | 5.3 % | 5.9 % | 1.09 | — | 41.3 | 3.3 | 186.4 | 93.8 | 4.39 | 51.0 | -3.3 % | 75.6 % | -6.6 % | 0.0 % | 2.0 % | -7.38 | -8.0 % | +22.2 % | 5 | 0.0 % | 0.0 % | -9.8 | 59.3 % | 9.3 % | 4.9 (7) | |
| PDSB PDS Biotechnology Corp | 08/12 | -28 % | 82 7/22 | Stage 2 | D 27 | 1 of 9 | 0.0 $ | Biotechnology | – | — | — | Healthcare | 0.69 $ | +18.5 % | +0.6 % | -35.9 % | −44.8 % | +742.7 % | 53 | 42 | 9.6 % | 11.2 % | 1.58 | — | 0.0 | — | 9.7 | — | — | -2.6 | — | — | 0.0 % | -254.1 % | -50.5 % | 4.08 | — | — | 2 | 0.0 % | 0.0 % | -28.7 | 9.2 % | 2.8 % | — |
| EOLS Evolus Inc | 08/04 | -5 % | 40 4/22 | Stage 3 | C 46 | 4 of 9 | 0.4 $ | Drug Manufacturers - Specialty & Generic | – | — | — | Healthcare | 5.80 $ | +1.4 % | +4.1 % | -34.5 % | −29.9 % | +152.9 % | 52 | 42 | 4.7 % | 4.9 % | 1.32 | — | 53.2 | 1.3 | — | — | — | -21.5 | — | 66.1 % | -14.4 % | -18,729.6 % | -9.1 % | — | — | +11.6 % | — | 0.0 % | 0.0 % | -5.4 | 70.1 % | 9.1 % | 4.6 (7) |
| OBIO Orchestra BioMed Holdings Inc. | 08/11 | -17 % | 7 1/22 | Stage 1 | D 39 | 3 of 9 | 0.2 $ | Biotechnology | – | — | — | Healthcare | 4.00 $ | -2.7 % | +9.7 % | +30.1 % | −28.1 % | +212.0 % | 52 | 42 | 6.7 % | 5.4 % | 0.48 | — | 0.0 | 7.3 | 6.3 | — | — | -1.8 | — | 99.5 % | -167.0 % | -161.1 % | -43.0 % | 0.66 | — | +1,169.2 % | — | 0.0 % | 0.0 % | -6.3 | 41.7 % | 3.4 % | — |
| STHO Star Holdings | 08/06 | -11 % | 45 4/21 | Stage 2 | D 43 | 4 of 9 | 0.1 $ | Real Estate Services | – | — | — | Real Estate | 9.20 $ | +8.3 % | +19.7 % | +30.3 % | −2.7 % | — | 51 | 2 | 2.1 % | 2.2 % | 1.23 | — | 0.0 | 1.2 | 0.5 | — | — | 2.7 | — | 33.5 % | -53.8 % | -26.8 % | 2.5 % | 0.87 | — | +24.0 % | 3 | 0.0 % | 0.0 % | -1.5 | 75.1 % | 1.3 % | — |
| RARE Ultragenyx | 08/04 | -14 % | 69 6/22 | Stage 3 | D 37 | 0 of 9 | 2.5 $ | Biotechnology | – | — | — | Healthcare | 24.90 $ | +25.0 % | -11.3 % | -8.8 % | −31.0 % | +114.3 % | 48 | 42 | 5.5 % | 5.2 % | 0.31 | — | 0.0 | 3.7 | — | — | — | -6.5 | -102.2 % | -28.1 % | -90.9 % | -608.5 % | -25.5 % | — | -18.2 % | +20.1 % | — | 0.0 % | 0.0 % | -9.9 | 104.2 % | 14.1 % | 4.6 (20) |
| SPRY ARS Pharmaceuticals, Inc | 08/12 | +21 % | — | Stage 3 | D 39 | 3 of 9 | 0.0 $ | Biotechnology | – | — | — | Healthcare | 5.10 $ | -11.8 % | -25.4 % | -71.0 % | −57.6 % | +264.7 % | 46 | 50 | 8.8 % | 7.9 % | 0.88 | — | 0.0 | — | 12.0 | — | — | -9.9 | — | 59.4 % | -200.0 % | -136.4 % | -41.2 % | 1.57 | — | -5.5 % | 5 | 0.0 % | 0.0 % | -0.6 | 95.5 % | 33.6 % | — |
| RGNX Regenxbio Inc | 08/06 | -16 % | 15 2/22 | Stage 4 | D 27 | 1 of 9 | 0.5 $ | Biotechnology | – | — | — | Healthcare | 9.70 $ | -30.9 % | -18.2 % | +13.9 % | −36.8 % | +150.2 % | 46 | 42 | 13.1 % | 9.4 % | 0.90 | — | 0.0 | 5.6 | — | — | 0.26 | -3.4 | — | -196.6 % | 0.0 % | -196.4 % | -38.5 % | — | — | +104.5 % | 3 | 0.0 % | 0.0 % | -10.9 | 84.7 % | 18.0 % | 4.4 (12) |
| RVSB Riverview Bancorp Inc | 08/04 | +8 % | 58 5/22 | Stage 2 | D 33 | 4 of 9 | 0.1 $ | Banks - Regional | – | — | — | Financial Services | 5.30 $ | +14.8 % | +3.5 % | +9.1 % | −12.2 % | +28.2 % | 46 | 61 | 5.0 % | 3.6 % | 0.48 | — | 37.0 | 1.7 | 0.7 | 9.9 | 1.42 | 0.0 | — | 100.0 % | -10.4 % | -2.8 % | -0.3 % | 0.31 | — | -11.6 % | 3 | 1.5 % | 38.1 % | -1.4 | 73.4 % | 2.2 % | — |
| OSTX OS Therapies Incorporated | 08/17 | — | 82 7/22 | Stage 3 | D 27 | 2 of 9 | 0.1 $ | Biotechnology | – | — | — | Healthcare | 1.50 $ | +30.0 % | +47.4 % | -14.6 % | −30.0 % | +422.1 % | 45 | 42 | 8.5 % | 8.3 % | — | — | 1.7 | — | 11.4 | — | — | 0.0 | — | — | 0.0 % | -914.0 % | -366.6 % | -0.12 | — | — | — | 0.0 % | 0.0 % | -78.9 | 6.5 % | 4.9 % | — |
| TCBX Third Coast Bancshares, Inc. | 07/22 | +45 % | — | Stage 3 | C 50 | 4 of 9 | 0.0 $ | Banks - Regional | – | — | — | Financial Services | 43.80 $ | +4.9 % | +1.1 % | +16.4 % | −8.0 % | +5.9 % | 44 | 50 | 2.5 % | 2.4 % | 0.65 | 10.8 | 10.4 | — | 1.1 | — | — | 0.0 | — | 100.0 % | 32.4 % | 12.2 % | 1.2 % | 0.24 | — | +8.5 % | 4 | 0.0 % | 0.0 % | -1.5 | 57.0 % | 3.0 % | — |
| SPCE Virgin Galactic Holdings Inc | 08/05 | -32 % | 18 3/29 | Stage 1 | D 40 | 3 of 9 | 0.3 $ | Aerospace & Defense | Neutral | — | Industrials | 2.60 $ | -6.5 % | -12.0 % | -32.9 % | −71.9 % | +42.0 % | 43 | 42 | 11.4 % | 18.9 % | 2.74 | — | 0.0 | 220.0 | — | — | — | -0.1 | — | -6,127.7 % | 0.0 % | -104.5 % | -19.8 % | — | — | -78.1 % | — | 0.0 % | 0.0 % | -10.8 | 15.8 % | 32.4 % | — | |
| CNVS Cineverse Corp. | 08/13 | +12 % | 84 8/24 | Stage 3 | D 34 | 1 of 9 | 0.1 $ | Entertainment | – | — | — | Communication Services | 2.40 $ | +35.1 % | +34.0 % | -52.4 % | −63.7 % | +291.8 % | 43 | 42 | 10.7 % | 7.1 % | 1.52 | — | 38.8 | 0.9 | — | — | 0.46 | 10.1 | — | 53.4 % | -13.4 % | -24.5 % | -9.3 % | — | — | +59.1 % | — | 0.0 % | 0.0 % | -20.6 | 16.5 % | 2.7 % | — |
| WAL Western Alliance Bancorporation | 07/16 | +49 % | 1 0/22 | Stage 1 | C 50 | 4 of 9 | 8.6 $ | Banks - Regional | – | — | — | Financial Services | 80.50 $ | -3.0 % | -3.4 % | +5.9 % | −16.2 % | +14.7 % | 42 | 28 | 2.9 % | 2.9 % | 1.33 | 9.4 | 8.0 | 2.0 | 1.2 | — | 1.47 | 0.0 | 31.8 % | 100.0 % | 28.2 % | 13.0 % | 1.1 % | 0.90 | 7.7 % | +5.2 % | 5 | 2.1 % | 20.5 % | -1.0 | 87.1 % | 0.0 % | 4.2 (15) |
| BCRX BioCryst Pharmaceuticals Inc | 08/03 | +11 % | 80 7/22 | Stage 2 | D 42 | 2 of 9 | 2.3 $ | Drug Manufacturers - Specialty & Generic | – | — | — | Healthcare | 9.00 $ | +19.4 % | +24.0 % | +10.3 % | −9.5 % | +133.3 % | 42 | 42 | 5.9 % | 4.7 % | 0.54 | — | 87.0 | 2.6 | 51.4 | 7.7 | 9.39 | 7.2 | -2.5 % | 76.6 % | -51.7 % | -1,925.4 % | 42.6 % | -1.55 | -119.1 % | +94.1 % | 7 | 0.0 % | 0.0 % | -15.9 | 101.1 % | 12.4 % | 4.4 (12) |
| ELUT Elutia Inc. | 08/13 | -20 % | 93 9/22 | Stage 2 | D 32 | 3 of 9 | 0.0 $ | Medical Devices | – | — | — | Healthcare | 0.86 $ | +48.7 % | +71.0 % | -57.8 % | −64.1 % | +426.3 % | 41 | 42 | 7.1 % | 8.1 % | 0.85 | — | 0.0 | 2.7 | 1.8 | — | — | -3.3 | — | 56.3 % | 400.2 % | 0.0 % | -26.4 % | 0.52 | — | -49.6 % | — | 0.0 % | 0.0 % | -7.2 | 45.7 % | 0.1 % | — |
| NG NovaGold Resources Inc | — | +19 % | 11 2/23 | Stage 4 | D 29 | 4 of 9 | 2.5 $ | Gold | – | — | — | Basic Materials | 5.80 $ | -22.5 % | -39.5 % | +12.3 % | −57.3 % | +139.8 % | 40 | 42 | 8.2 % | 6.7 % | 2.15 | — | 4.9 | — | — | — | 1.34 | -40.4 | 0.0 % | — | 0.0 % | -52.0 % | -4.4 % | — | 70.3 % | -100.0 % | 1 | 0.0 % | 0.0 % | -2.2 | 79.3 % | 8.3 % | 4.4 (8) |
| BETR Better Home & Finance Holding Company | 08/12 | -33 % | — | Stage 4 | D 42 | 3 of 9 | 0.0 $ | Mortgage Finance | – | — | — | Financial Services | 23.50 $ | -21.1 % | -28.2 % | +81.6 % | −72.8 % | +61.1 % | 40 | 50 | 9.0 % | 8.7 % | 1.73 | — | 0.0 | — | — | — | — | -0.9 | — | 100.0 % | -102.5 % | -875.5 % | -13.2 % | — | — | +59.4 % | 4 | 0.0 % | 0.0 % | -1.0 | 46.6 % | 23.1 % | — |
| CD Chaince Digital Holdings Inc. | — | +5 % | 89 8/22 | Stage 4 | D 30 | 3 of 9 | 0.2 $ | Capital Markets | Neutral | — | Financial Services | 2.80 $ | -5.8 % | -20.4 % | -32.3 % | −88.1 % | — | 40 | 42 | 11.2 % | 15.7 % | 8.44 | — | 0.0 | 84.4 | 4.7 | — | — | 200.9 | — | 62.2 % | -219.1 % | -6.9 % | -5.7 % | — | — | +85.3 % | — | 0.0 % | 0.0 % | -17.8 | 24.1 % | 4.2 % | — | |
| GRPN Groupon Inc | 08/05 | +68 % | 84 8/24 | Stage 3 | D 36 | 3 of 9 | 1.1 $ | Internet Content & Information | Uses AI | — | Communication Services | 27.60 $ | -4.8 % | +29.9 % | -10.6 % | −46.9 % | -4.6 % | 38 | 86 | 9.3 % | 8.9 % | 0.22 | — | 153.8 | 2.1 | 21.4 | 26.3 | 14.66 | 17.4 | — | 90.7 % | -20.8 % | -15.2 % | 0.8 % | -5.02 | — | +1.2 % | 4 | 0.0 % | 0.0 % | -7.0 | 148.1 % | 59.9 % | 4.0 (4) | |
| RCKT Rocket Pharmaceuticals Inc | 08/06 | -28 % | 40 4/22 | Stage 4 | D 30 | 1 of 9 | 0.3 $ | Biotechnology | – | — | — | Healthcare | 3.10 $ | -1.1 % | -4.0 % | +2.0 % | −40.6 % | +202.8 % | 37 | 42 | 7.3 % | 6.4 % | 0.45 | — | 0.0 | — | — | — | — | 1.6 | — | — | 0.0 % | -64.4 % | -35.1 % | — | — | — | — | 0.0 % | 0.0 % | -10.4 | 89.9 % | 18.6 % | 4.6 (18) |
| ACH Accendra Health Inc | 08/10 | -28 % | — | Stage 3 | D 31 | 2 of 9 | 0.0 $ | Medical Distribution | – | — | — | Healthcare | 3.10 $ | +11.8 % | +27.3 % | -55.4 % | −66.8 % | +41.6 % | 37 | 50 | 7.2 % | 8.1 % | 1.58 | — | 2.9 | — | 1.0 | — | 0.70 | 8.9 | — | 46.0 % | -39.8 % | -198.4 % | 1.6 % | -4.67 | — | -74.2 % | 3 | 0.0 % | 0.0 % | 0.2 | 85.9 % | 10.7 % | — |
| SABR Sabre Corporation | 08/06 | -15 % | 73 7/25 | Stage 3 | C 46 | 4 of 9 | 0.8 $ | Software - Infrastructure | Sells AI | — | Technology | 1.90 $ | +28.7 % | +47.2 % | -38.9 % | −46.9 % | +4.7 % | 36 | 6 | 9.0 % | 7.4 % | 0.96 | — | 37.7 | 0.3 | 147.4 | — | 1.68 | 12.7 | — | 56.5 % | 17.6 % | -737.4 % | 5.1 % | -4.10 | — | -8.5 % | 4 | 0.0 % | 0.0 % | 0.0 | 90.2 % | 11.0 % | 3.7 (7) | |
| NN Nextnav Acquisition Corp | 08/05 | +156 % | 95 11/25 | Stage 1 | E 21 | 3 of 9 | 1.8 $ | Software - Infrastructure | Neutral | — | — | Technology | 13.10 $ | +2.9 % | +4.6 % | -11.4 % | −31.7 % | +157.0 % | 35 | 42 | 7.7 % | 8.5 % | 1.07 | — | 0.0 | 445.5 | 187.7 | — | — | -1.6 | -1,913.9 % | -101.8 % | 0.0 % | -706.8 % | -17.3 % | -3.13 | -38.2 % | -19.3 % | 2 | 0.0 % | 0.0 % | -11.9 | 71.0 % | 15.9 % | 4.0 (2) |
| PCT Purecycle Technologies Holdings Co | 08/06 | -4 % | 85 10/29 | Stage 4 | D 38 | 2 of 9 | 1.3 $ | Pollution & Treatment Controls | – | — | — | Industrials | 6.40 $ | -3.5 % | -17.9 % | -52.5 % | −54.5 % | +78.1 % | 34 | 42 | 7.1 % | 8.1 % | 2.51 | — | 142.9 | 119.4 | 175.4 | — | — | -11.0 | — | -970.5 % | 0.0 % | -80.9 % | -12.7 % | 99.53 | — | — | 2 | 0.0 % | 0.0 % | -0.6 | 69.1 % | 38.8 % | 4.0 (4) |
| PESI Perma-Fix Environmental Svcs Inc | 08/06 | 0 % | 37 5/29 | Stage 4 | D 30 | 3 of 9 | 0.3 $ | Waste Management | Neutral | — | — | Industrials | 16.60 $ | -11.9 % | +3.6 % | +44.1 % | −25.8 % | +50.6 % | 34 | 15 | 7.2 % | 7.1 % | 0.45 | — | 99.0 | 5.9 | — | — | — | -31.4 | — | 4.1 % | -30.1 % | -28.5 % | -11.1 % | — | — | +4.3 % | — | 0.0 % | 0.0 % | -1.0 | 49.3 % | 11.7 % | 5.0 (1) |
| ELWT Elauwit Connection, Inc. Common Stock | 08/13 | — | 94 10/24 | Stage 1 | D 36 | 3 of 9 | 0.1 $ | Telecom Services | – | — | — | Communication Services | 8.20 $ | +18.9 % | +30.7 % | — | −36.8 % | +95.4 % | 31 | 42 | 10.5 % | 10.2 % | — | — | 0.0 | 2.6 | 23.9 | — | — | 0.0 | — | 17.3 % | -28.9 % | 0.0 % | -35.6 % | 0.82 | — | +154.5 % | — | 0.0 % | 0.0 % | -4.6 | 8.6 % | 1.1 % | — |
| BAER Bridger Aerospace Group Holdings, Inc. Common Stock | 08/06 | -24 % | 18 3/29 | Stage 1 | D 37 | 2 of 9 | 0.1 $ | Security & Protection Services | – | — | — | Industrials | 1.90 $ | -5.5 % | +5.9 % | +12.8 % | −51.7 % | +148.0 % | 30 | 66 | 5.7 % | 7.2 % | 0.36 | — | 11.0 | 1.0 | — | — | — | 28.3 | — | 38.6 % | -10.1 % | -31.6 % | 0.1 % | — | — | +24.6 % | 6 | 0.0 % | 0.0 % | -1.2 | 40.5 % | 4.7 % | — |
| BSIN Big Sky Industrial Inc. | 08/11 | -8 % | 57 2/10 | Stage 3 | D 36 | 3 of 9 | 0.1 $ | Oil & Gas E&P | – | — | — | Energy | 1.10 $ | +15.2 % | +10.3 % | -5.0 % | −37.3 % | +159.4 % | 30 | 42 | 6.1 % | 6.9 % | 0.74 | — | 83.3 | 9.3 | 1.5 | — | — | 10.4 | — | 27.6 % | -231.4 % | -40.1 % | -15.8 % | 0.07 | — | -64.3 % | — | 0.0 % | 0.0 % | -8.1 | 20.6 % | 5.1 % | — |
| SYPR Sypris Solutions Inc | 08/11 | +9 % | 52 7/31 | Stage 1 | D 33 | 3 of 9 | 0.0 $ | Auto Parts | – | — | — | Consumer Cyclical | 1.90 $ | -2.5 % | +0.8 % | -1.1 % | −52.1 % | -44.9 % | 30 | 64 | 6.3 % | 8.9 % | 0.88 | — | 7.0 | 0.4 | 3.2 | — | 2.28 | 37.6 | — | 5.9 % | -8.2 % | -58.3 % | -6.2 % | 0.90 | — | -14.5 % | — | 0.0 % | 0.0 % | -0.3 | 19.9 % | 0.3 % | — |
| CDZI Cadiz Inc | 08/12 | +1 % | 50 3/15 | Stage 4 | D 39 | 3 of 9 | 0.3 $ | Utilities - Regulated Water | – | — | — | Utilities | 3.00 $ | -27.5 % | -32.0 % | -6.0 % | −47.6 % | +219.6 % | 29 | 42 | 6.6 % | 6.7 % | 1.83 | — | 14.9 | 16.8 | — | — | 1.51 | -25.1 | — | 31.4 % | -221.4 % | -111.3 % | -10.7 % | — | — | +69.8 % | — | 0.0 % | 0.0 % | -12.9 | 48.8 % | 12.5 % | — |
| RIVN Rivian Automotive Inc | 08/04 | +3 % | 78 10/31 | Stage 1 | C 50 | 4 of 9 | 20.5 $ | Auto Manufacturers | – | — | — | Consumer Cyclical | 15.20 $ | -24.5 % | -20.4 % | +18.3 % | −34.5 % | +26.0 % | 28 | 42 | 5.7 % | 6.3 % | 1.60 | — | 0.0 | 3.5 | 4.6 | — | — | -2.0 | -63.8 % | 7.5 % | -55.0 % | -65.7 % | -14.4 % | 1.49 | 30.9 % | +8.4 % | 4 | 0.0 % | 0.0 % | -2.4 | 42.0 % | 12.4 % | 3.5 (29) |
| GROV Grove Collaborative Holdings, Inc. | 08/06 | -9 % | 65 4/16 | Stage 4 | C 45 | 4 of 9 | 0.0 $ | Household & Personal Products | – | — | — | Consumer Defensive | 1.10 $ | +10.9 % | +9.4 % | -21.4 % | −32.1 % | +60.0 % | 28 | 42 | 5.6 % | 6.3 % | 1.04 | — | 0.1 | 0.3 | — | — | — | -3.4 | — | 54.1 % | -5.5 % | -89.6 % | -9.8 % | — | — | -14.6 % | — | 0.0 % | 0.0 % | -38.9 | 30.4 % | 9.3 % | — |
| PACB Pacific Biosciences of California | 08/06 | -30 % | 15 2/22 | Stage 4 | D 32 | 3 of 9 | 0.4 $ | Medical Devices | – | — | — | Healthcare | 1.40 $ | -29.9 % | -8.0 % | +1.5 % | −41.4 % | +75.6 % | 26 | 42 | 8.6 % | 8.4 % | 2.29 | — | 0.0 | 2.7 | 189.5 | — | — | 140.8 | — | 38.3 % | -80.4 % | -273.6 % | -12.0 % | 297.29 | — | +3.9 % | — | 0.0 % | 0.0 % | -6.5 | 54.0 % | 17.1 % | 3.8 (14) |
| MDAI Spectral AI Inc. | 08/11 | -28 % | 70 6/22 | Stage 3 | D 27 | 1 of 9 | 0.0 $ | Medical Devices | – | — | — | Healthcare | 1.60 $ | +20.4 % | +17.4 % | -37.5 % | −48.0 % | +224.4 % | 26 | 42 | 4.9 % | 7.9 % | 1.17 | — | 52.4 | 2.8 | — | — | — | -3.4 | — | 46.0 % | -82.0 % | -2,308.3 % | -31.5 % | — | — | -33.6 % | — | 0.0 % | 0.0 % | -14.9 | 15.2 % | 10.5 % | — |
| OM Outset Medical Inc | 08/05 | -33 % | 7 1/22 | Stage 3 | D 37 | 4 of 9 | 0.1 $ | Medical Devices | – | — | — | Healthcare | 4.60 $ | +28.3 % | +31.6 % | -71.5 % | −78.5 % | +67.0 % | 24 | 42 | 11.0 % | 9.7 % | 1.94 | — | 0.0 | 0.7 | — | — | — | -0.2 | — | 40.6 % | -63.7 % | -53.2 % | -15.3 % | — | — | +5.1 % | — | 0.0 % | 0.0 % | -7.8 | 84.2 % | 14.5 % | — |
| FTCI FTC Solar Inc | 08/04 | -30 % | 62 6/25 | Stage 4 | C 53 | 4 of 9 | 0.0 $ | Solar | – | — | — | Technology | 2.80 $ | -52.2 % | -58.7 % | -51.8 % | −64.2 % | +124.8 % | 22 | 42 | 9.6 % | 9.9 % | 1.81 | — | 18.8 | 0.4 | 7.5 | — | — | -0.7 | — | 1.4 % | -44.9 % | -955.8 % | -25.3 % | -3.81 | — | +110.5 % | 3 | 0.0 % | 0.0 % | -10.6 | 10.1 % | 9.0 % | — |
| DYAI Dyadic International Inc | 08/12 | -20 % | 93 9/22 | Stage 4 | C 50 | 3 of 9 | 0.0 $ | Biotechnology | – | — | — | Healthcare | 1.10 $ | -14.3 % | -10.6 % | -0.9 % | −45.0 % | +710.8 % | 21 | 42 | 11.8 % | 9.7 % | 1.15 | — | 6.8 | 13.3 | 31.2 | — | — | -2.9 | — | 26.1 % | -191.5 % | -2,826.9 % | -56.2 % | -12.39 | — | -64.7 % | 4 | 0.0 % | 0.0 % | -34.1 | 15.0 % | 0.5 % | — |
| TELO Telomir Pharmaceuticals, Inc. Common Stock | 08/13 | — | 17 2/22 | Stage 4 | D 32 | 4 of 9 | 0.1 $ | Biotechnology | – | — | — | Healthcare | 1.20 $ | -6.0 % | -12.0 % | -35.3 % | −60.3 % | +1,160.2 % | 21 | 42 | 6.0 % | 5.5 % | -0.24 | — | 0.0 | — | 17.0 | — | — | 0.0 | — | — | 0.0 % | -384.3 % | -186.9 % | 0.04 | — | — | — | 0.0 % | 0.0 % | -14.4 | 3.3 % | 1.7 % | — |
| BKKT Bakkt Holdings Inc | 08/10 | -30 % | 20 3/25 | Stage 4 | E 19 | 3 of 9 | 0.3 $ | Software - Infrastructure | – | — | — | Technology | 7.20 $ | -11.7 % | -23.3 % | -27.6 % | −84.3 % | +142.7 % | 20 | 42 | 9.7 % | 10.7 % | 5.90 | — | 0.0 | 0.2 | 2.0 | — | — | 0.8 | — | -6.9 % | -8.4 % | -102.0 % | -37.4 % | 0.00 | — | -33.1 % | — | 0.0 % | 0.0 % | -7.7 | 21.4 % | 25.0 % | — |
| TVGN Tevogen Bio Holdings Inc. | 08/18 | -33 % | 58 5/22 | Stage 4 | E 19 | 4 of 9 | 0.0 $ | Biotechnology | – | — | — | Healthcare | 7.10 $ | -42.5 % | -68.2 % | -85.7 % | −20.7 % | -79.0 % | 20 | 42 | 12.9 % | 16.1 % | 0.22 | — | 0.0 | — | 0.0 | — | — | 18.3 | — | — | 0.0 % | 0.0 % | -294.4 % | -0.31 | — | — | — | 0.0 % | 0.0 % | -129.5 | 3.6 % | 5.3 % | — |
| EVLV Evolv Technologies Holdings Inc | 08/13 | -2 % | 85 10/29 | Stage 4 | C 47 | 3 of 9 | 1.0 $ | Security & Protection Services | – | — | — | Industrials | 5.50 $ | -22.6 % | -15.8 % | -15.6 % | −41.3 % | +84.1 % | 19 | 42 | 4.8 % | 4.8 % | 1.77 | — | 43.3 | 6.2 | 8.6 | — | — | -5.1 | — | 49.8 % | -22.8 % | -30.2 % | -5.8 % | 0.35 | — | +40.5 % | 6 | 0.0 % | 0.0 % | -0.5 | 72.9 % | 5.2 % | 4.5 (4) |
Price Chart
Quarterly Figures
No quarterly data available.
Frequently Asked Questions
Going concern refers to serious doubt about whether a company can continue to operate. This scanner takes the classic warning signs: Altman Z″ in the distress zone (<1.1), interest coverage <1 (earnings don't cover interest), and negative operating cash flow (burning cash).
All scanners are recalculated daily across the entire stock universe — most recently on 3. August 2026. The data basis is fundamental data and SEC filings (10-K annual reports and 10-Q quarterly reports).
Currently, 161 stocks pass this scanner's criteria (as of 3. August 2026). The 100 strongest hits are shown.
Global filters: market cap of $50B or less (mega caps are cut from every scanner); 10- and 30-day ADR must be ≥ 1% (too little movement gets cut); fundamentally healthy names (Piotroski ≥ 5 or Fundamental Rating ≥ 55 out of 100) are excluded.
This scanner deliberately hunts for red flags — a hit is a finding, not a recommendation: like a smoke detector that beeps so you look in time. A hit is also not a bankruptcy verdict; most companies save themselves (say, through a capital raise, which dilutes existing shareholders). Portfolio owners use the list as an early-warning system, bargain hunters as an anti-shopping list, experienced traders as a watch list — it is never a buy or short recommendation.
Related scanners
- Altman Z: Distress Zone
- Bankruptcy Study: Stacked Warning Signals
- Below the 50- & 200-SMA
- Beneish M-Score
- Downward Momentum
- Insolvency Radar: Cash Running Low
- Kathy Donnelly: Liquid Movers Down
- Mike Webster: Overextended (Webby RSI)
- Near 52-Week Low
- Pradeep Bonde: $ Breakout Bearish
- Pradeep Bonde: 4% Breakout Bearish
- Qullamaggie: Parabolic (Short-Watch)
- RS Weakness (≤10)
- Stage 4 (Downtrend)
- Stan Weinstein: Stage 4
- Stan Weinstein: Stage 4B-
- Thomas Insolvency Candidate
- Weakness Cluster
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.